The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability- high Metastatic Colorectal Cancer

The Efficacy of Immune Checkpoint Inhibitors as First-line Treatment in Microsatellite-instability- high Metastatic Colorectal Cancer

Bibliographic Details
Main Author:	Jong Yoon Lee
Format:	Article
Language:	English
Published:	Jin Publishing & Printing Co. 2021-05-01
Series:	The Korean Journal of Gastroenterology
Online Access:	http://www.kjg.or.kr/journal/view.html?uid=5709&vmd=Full

Similar Items

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency
by: Romain Cohen, et al.
Published: (2021-03-01)

Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
by: Alessandra Raimondi, et al.
Published: (2021-04-01)

Current Treatments of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitors—2020 Update
by: Gerhard Jung, et al.
Published: (2020-10-01)

63 Microsatellite instability/mismatch repair biomarker testing disparities in patients with advanced colorectal cancer: Implications for immune checkpoint inhibitors
by: Bryan Iorgulescu
Published: (2020-11-01)

Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer
by: Salomon M. Manz, et al.
Published: (2021-04-01)

Treatment Efficacy of Immune Checkpoint Inhibitors for Patients with Advanced or Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
by: Junhee Pyo, et al.
Published: (2021-08-01)

Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment
by: Lin Shen, et al.
Published: (2020-07-01)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
by: Federica Marmorino, et al.
Published: (2020-08-01)

Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes
by: Dmitrii Shek, et al.
Published: (2021-08-01)

Immune Checkpoint Inhibitor in First-Line Treatment of Metastatic Renal Cell Carcinoma: A Review of Current Evidence and Future Directions
by: Iris Tung, et al.
Published: (2021-08-01)

Multi-organ sarcoidosis like reaction mimics metastatic disease in a microsatellite instability-high melanoma patient treated with checkpoint inhibitors
by: Geetha Jagannathan, et al.
Published: (2020-03-01)

EMAST is associated with a poor prognosis in microsatellite instable metastatic colorectal cancer.
by: Sabine Venderbosch, et al.
Published: (2015-01-01)

Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients
by: Francesca Pirini, et al.
Published: (2020-05-01)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
by: Teresa Kim, et al.
Published: (2014-12-01)

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer
by: Jose M. Pacheco, et al.
Published: (2019-03-01)

Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers
by: Vito Amodio, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitors for the Treatment of Central Nervous System (CNS) Metastatic Disease
by: Suneel D. Kamath, et al.
Published: (2018-09-01)

Microsatellite instability in colorectal and oesophageal cancer.
by: Naidoo, Richard.
Published: (2011)

A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype
by: Marina Baretti, et al.
Published: (2021-05-01)

Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer
by: Wen-juan Huang, et al.
Published: (2020-11-01)

Research Progress of Immune Checkpoint Inhibitors in Colorectal Cancer
by: ZHUANG Yuwen, et al.
Published: (2020-07-01)

Prognostic value of microsatellite instability in adjuvant treatment of colorectal cancer
by: Oleksii A. Potapov, et al.
Published: (2018-08-01)

Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma
by: Jianhua Liu, et al.
Published: (2018-01-01)

191 Association of immune related adverse events with the efficacy of immune checkpoint inhibitors in metastatic renal cell carcinoma
by: Leonard Appleman, et al.
Published: (2020-11-01)

Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials
by: Hsiao-Ling Chen, et al.
Published: (2021-03-01)

Cetuximab for the first-line treatment of metastatic colorectal cancer
by: C Meads, et al.
Published: (2010-05-01)

Cetuximab in first line treatment of metastatic colorectal cancer
by: Carlo Barone, et al.
Published: (2012-07-01)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
by: Siteng Chen, et al.
Published: (2020-08-01)

Beyond First-Line Immune Checkpoint Inhibitor Therapy in Patients With Hepatocellular Carcinoma
by: Rohini Sharma, et al.
Published: (2021-03-01)

Characterizing Microsatellite Instability and Chromosome Instability in Interval Colorectal Cancers
by: Amy L. Cisyk, et al.
Published: (2018-09-01)

Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcer
by: Jungić Saša, et al.
Published: (2017-01-01)

Microsatellite Instability on the management and prognosis of colorectal cancer
by: Henrique Manuel Rodrigues Couto Teixeira
Published: (2019)

Subtyping of microsatellite instability-high colorectal cancer
by: Wangxiong Hu, et al.
Published: (2019-07-01)

Microsatellite Instability in Mouse Models of Colorectal Cancer
by: Nicola Currey, et al.
Published: (2018-01-01)

The Influence of Microsatellite Instability on Survival in Colorectal Cancer
by: Phillips, Simon M.
Published: (2005)

Efficacy and Immune Mechanisms of Cetuximab for the Treatment of Metastatic Colorectal Cancer
by: Hao Zhuang, et al.
Published: (2011-12-01)

Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer
by: Romain Cohen, et al.
Published: (2021-02-01)

KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician
by: Afrăsânie Vlad-Adrian, et al.
Published: (2019-09-01)

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects
by: Shima Makaremi, et al.
Published: (2021-08-01)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
by: Passiglia F, et al.
Published: (2021-02-01)